Download Our Northern Ireland Protocol Pharmaceutical Guide
How will the Northern Ireland Protocol impact companies in the pharmaceutical sector? That is a question that we have been asked many times in recent months. The issue of the Northern Ireland Protocol has continued to be a source of disquiet and uncertainty for life science companies. With that in mind, we have created a brief guide on the protocol. The guide answers some of the most commonly asked questions that we have received by email in recent weeks. If you have any questions about the Northern Ireland Protocol and its impact on medicinal products, or another Brexit-related question, you can submit it in the form at the end of this page.
This article is part of our extensive Brexit coverage. You can access all of our Brexit articles, e-books, and guides by clicking here.
The guide answers:
- What Is The Northern Ireland Protocol?
- Why Is It Being Introduced?
- What Impact Will the Northern Ireland Protocol Have On the Pharmaceutical Industry?
- What Is An Impacted Medicinal Product?
and finally, we offer our advice on how you and your company can best manage the situation.